Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05024318
Title NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

renal cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field